Circuit-specific gene editing for precision modulation of neuronal activity with CRISPR-rabies virus
Zhang, Z.; Xu, J.; Matthews, E. A.; Deasy, S.; He, L.; Arroyo, D.; Pan, E.; Deshmukh, A.; Kaur, K. S.; McNamara, J. O.; Southwell, D. G.; Gersbach, C. A.; Ji, R. R. A.; Velmeshev, D.
Show abstract
CRISPR gene editing has revolutionized our ability to study and manipulate specific genes, enabling novel insights into gene function and potential therapies for brain disorders. Recent advances in cell-type-specific regulatory elements and viral delivery systems have made precise in vivo gene editing possible. However, neurons with similar molecular profiles can belong to different circuits, complicating efforts to manipulate circuit function and behavior. To address this, we developed CRISPR-rabies virus (CRV), which leverages the trans-synaptic spread of rabies virus to enable gene editing within anatomically defined neural circuits. By pairing CRV with cell type-specific Cas9 expression, we achieved targeted gene modifications in specific circuits. We demonstrate that CRV can modulate sodium and potassium channel expression in parvalbumin interneurons, thereby effectively regulating synaptic transmission of pyramidal neurons in the CA3 region of the hippocampus. Its compatibility with 3'-capture single-cell RNA-seq allows simultaneous circuit perturbation and molecular profiling. In summary, CRV allows precise circuit-level gene modulation, providing a platform for studying gene function in neural circuits and developing novel gene therapies for brain disorders.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- An arginine-rich nuclear localization signal (ArgiNLS) strategy for streamlined image segmentation of single-cells 97%
- CRISPR with Transcriptional Readout reveals influenza transcriptionis modulated by NELF and can precipitate an interferon response 95%
- Orthogonal genome-wide screenings in bat cells identify MTHFD1 as a target of broad antiviral therapy 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.